Gesamtlänge aller Episoden: 1 day 21 hours 21 minutes
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
Visit https://www.peervoice.com/QZR860 to view the entire programme with slides.
A Closer Look at Safety of Glucose-Lowering Therapy
Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety
Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
Considering the Possibility of Psoriatic Arthritis in Patients With Psoriasis
Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know
Go online to www.peervoice.com/XQA860 to view the entire programme with slides.
SGLT2 Inhibitors: From A1C to Cardiac and Renal Outcomes
Go online to www.peervoice.com/KHM860 to view the entire programme with slides.